
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1073 | 1061 | 1144 | 1233 | 1529 | 2221 |
Fund Return | 7.3% | 6.09% | 14.38% | 7.24% | 8.87% | 8.3% |
Place in category | 652 | 610 | 318 | 12 | 41 | 10 |
% in Category | 88 | 83 | 49 | 3 | 11 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
zCapital Swiss Small Mid Cap ZA CH | 1.08B | 6.06 | -0.02 | 8.97 | ||
zCapital Swiss Small Mid Cap Fund | 1.08B | 5.13 | 0.59 | 7.28 | ||
zCapital Swiss Dividend Fund ZA | 801.37M | 9.88 | 8.35 | 8.84 | ||
Precious Capital Global Mining and | 145.99M | 29.33 | -5.37 | 12.34 | ||
Swiss Opportunity Fund | 69.58M | 1.47 | -7.12 | 5.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.66B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquiI | 2.26B | 10.19 | 3.38 | 7.31 | ||
Pictet CH Institutional Swiss EquZD | 2.26B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiP | 2.26B | 10.16 | 3.18 | 7.09 | ||
Pictet CH Institutional Swiss EquiZ | 2.26B | 8.90 | 2.54 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.92 | 291.50 | -1.75% | |
Novartis | CH0012005267 | 9.82 | 98.10 | -0.53% | |
Nestle | CH0038863350 | 9.75 | 90.30 | +0.07% | |
ABB | CH0012221716 | 5.26 | 45.05 | -4.07% | |
Zurich Insurance Group | CH0011075394 | 5.12 | 616.60 | -0.77% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review